Welcome to CDC Stacks | CDC recommendations for influenza antiviral medications remain unchanged - 25233 | Health Alert Network (HAN)
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
CDC recommendations for influenza antiviral medications remain unchanged
  • Published Date:
    2/9/12
  • Source:
    HAN ; 324
  • Language:
    English
Filetype[PDF - 1.36 MB]


Details:
  • Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
  • Series:
    HAN ; 324
  • Document Type:
  • Description:
    February 09, 2012, 15:00 EST

    CDCHAN-00324-ADV-N

    A recent review of randomized clinical trial data for the influenza neuraminidase inhibitor antiviral medications, and two related commentaries, raised questions about the value of antiviral medications for the prevention and treatment of influenza. On February 7, 2012, the Centers for Disease Control and Prevention (CDC) posted a "Have You Heard?" piece in response. The CDC response states "After careful consideration of all available evidence, CDC guidance on the use of antiviral medications remains unchanged." CDC continues to recommend the use of neuraminidase inhibitor antiviral drugs (oral oseltamivir and inhaled zanamivir) as an important adjunct in the prevention and treatment of influenza.

  • Supporting Files:
    No Additional Files